Donation

A quarterly publication of myeloma research from our medical editors

The IMF’s quarterly journal features scientific and clinical news and stories about education and awareness programs, patient meetings, and advocacy activities. Available online and by mail.

Do you want to read about the latest myeloma research, vetted by the IMF's Medical Editors? Also learn about worldwide events in the myeloma research community and gain inspiration from IMF donors and fundraisers. You can with the Myeloma Today!

The IMF’s quarterly journal features:

  • scientific and clinical news
  • reports from international medical meetings, such as ASCO and ASH
  • stories about educational outreach
  • pictures and summaries of our annual Myeloma Action Month initiative
  • information about advocacy initiatives and how you can get involved
  • the latest news from international and U.S.-based patient meetings
  • inspirational tales from patients, caregivers, donors, fundraisers, and more!
Sign Up to Receive the Myeloma Today Magazine

Stay Informed with Myeloma Today. Sign up today and stay up to date on the breakthroughs, events, and stories shaping the future of myeloma care.

b
Image Left
White
Sign Up to Receive Myeloma Today in French, Italian, German, or Spanish

Sign up today to receive free digital copies of Myeloma Today—our magazine packed with the latest research updates, treatment news, and patient stories—available in French, Italian, German, and Spanish. Stay informed, stay empowered, and stay connected to the global myeloma community. Sign up now to get your copy delivered straight to your inbox!

b
Image Left
White

The Summer Myeloma Today Edition has highlights of the 2021 IMWG Summit, 2021 ASCO and EHA Meeting Overview, Venetoclax Trials Showing Efficacy…

The Spring Myeloma Today Edition has recent COVID-19 information, CAR T-cell therapy made simple, 2021 ONS Satellite Symposium, Myeloma Action…

The latest edition of Myeloma Today – now available as a free download – features the recent approvals by the FDA of two new myeloma therapies,…

Highlights of Virtual 2020 Annual Meetings of ASCO and EHA, A New Class of Drugs, New Agents, and Clinical Trial Updates

Give Where Most Needed